Autologous Mesenchymal Stem Cells Show More Benefit on Systolic Function Compared to Bone Marrow Mononuclear Cells in a Porcine Model of Chronic Myocardial Infarction

Journal of Cardiovascular Translational Research

Volumn 8, Issue 7, 2015, Pages 393-403

  van der Spoel, T I G ^a   Gathier, W A ^a   Koudstaal, S ^a   van Slochteren, F ^a   of Lorkeers, S Jansen ^a   Sluijter, J P G ^a,b   Hoefer, I E ^c   Steendijk, P ^d   Cramer, M J M ^a   Doevendans, P A ^a,b   van Belle, E ^a   Chamuleau, S A J ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b ROYAL NETHERLANDS ACADEMY OF ARTS AND SCIENCES   (Netherlands)

^c Department of Experimental Cardiology ^*  (Netherlands)

^d LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Ischemic cardiomyopathy; Mesenchymal stem cell; Stem cells; Systolic function

Indexed keywords

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOLOGOUS STEM CELL TRANSPLANTATION; BONE MARROW DERIVED MONONUCLEAR CELL; BONE MARROW MONONUCLEAR CELL TRANSPLANTATION; CARDIAC MAPPING SYSTEM; CELL CULTURE; CELL THERAPY; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; CROSSOVER PROCEDURE; FEMALE; HEART EJECTION FRACTION; HEART FUNCTION; HEART INFARCTION; HEART OUTPUT; HISTOPATHOLOGY; INTERMETHOD COMPARISON; MESENCHYMAL STEM CELL TRANSPLANTATION; NONHUMAN; PORCINE MODEL; PRIORITY JOURNAL; REPERFUSION INJURY; SYSTOLIC FUNCTION; TRANSTHORACIC ECHOCARDIOGRAPHY; ANIMAL; AUTOTRANSPLANTATION; BONE MARROW TRANSPLANTATION; CHRONIC DISEASE; COMPARATIVE STUDY; DISEASE MODEL; ECHOCARDIOGRAPHY; HEART STROKE VOLUME; INTRAVENOUS ANESTHESIA; MYOCARDIAL INFARCTION; PATHOPHYSIOLOGY; PHYSIOLOGY; PIG; PREMEDICATION; PROCEDURES; SYSTOLE;

ANESTHESIA, INTRAVENOUS; ANIMALS; BONE MARROW TRANSPLANTATION; CELLS, CULTURED; CHRONIC DISEASE; DISEASE MODELS, ANIMAL; ECHOCARDIOGRAPHY; FEMALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MYOCARDIAL INFARCTION; PREMEDICATION; STROKE VOLUME; SWINE; SYSTOLE; TRANSPLANTATION, AUTOLOGOUS;

EID: 84945440244     PISSN: 19375387     EISSN: 19375395     Source Type: Journal    
DOI: 10.1007/s12265-015-9643-3     Document Type: Article

References (30)

1. Rosamond, W., Flegal, K., Furie, K., et al. (2008). Heart disease and stroke statistics—2008 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation, 117, e25–e146. doi:10.1161/ CIRCULATIONAHA.107.187998.
2. Abdel-Latif, A., Bolli, R., Tleyjeh, I. M., et al. (2007). Adult bone marrow-derived cells for cardiac repair: a systematic review and meta-analysis. Archives of Internal Medicine, 167, 989–997. doi:10.1001/archinte.167.10.989.
3. van der Spoel, T. I. G., of Lorkeers, S. J., Agostoni, P., et al. (2011). Human relevance of pre-clinical studies in stem cell therapy; systematic review and meta-analysis of large animal models of ischemic heart disease. Cardiovascular Research, 91, 649–658. doi:10.1093/cvr/cvr113.
4. Jeevanantham, V., Butler, M., Saad, A., Abdel-Latif, A., Zuba-Surma, E. K., & Dawn, B. (2012). Adult bone marrow cell therapy improves survival and induces long-term improvement in cardiac parameters/clinical perspective. Circulation, 126, 551–568. doi:10.1161/ CIRCULATIONAHA.111.086074.
5. van Ramshorst, J., Bax, J. J., Beeres, S. L., et al. (2009). Intramyocardial bone marrow cell injection for chronic myocardial ischemia: a randomized controlled trial. JAMA, 301, 1997–2004. doi:10.1001/jama.2009.685.
6. Perin, E. C., Silva, G. V., Assad, J. A., et al. (2008). Comparison of intracoronary and transendocardial delivery of allogeneic mesenchymal cells in a canine model of acute myocardial infarction. Journal of Molecular and Cellular Cardiology, 44, 486–495. doi:10.1016/j.yjmcc.2007.09.012.
7. Van der Spoel, T. I. G., Vrijsen, K. R., Koudstaal, S., et al. (2012). Transendocardial cell injection is not superior to intracoronary infusion in a porcine model of ischemic cardiomyopathy: a study on delivery efficiency. Journal of Cellular and Molecular Medicine, 16, 2768–2776. doi:10.1111/j.1582-4934.2012.01594.x.
8. Timmers, L., Henriques, J. P. S., de Kleijn, D. P. V., et al. (2009). Exenatide reduces infarct size and improves cardiac function in a porcine model of ischemia and reperfusion injury. Journal of the American College of Cardiology, 53, 501–510. doi:10.1016/j.jacc.2008.10.033.
9. Noort, W. A., Oerlemans, M. I. F. J., Rozemuller, H., et al. (2012). Human versus porcine mesenchymal stromal cells: phenotype, differentiation potential, immunomodulation and cardiac improvement after transplantation. Journal of Cellular and Molecular Medicine, 16, 1827–1839. doi:10.1111/j.1582-4934.2011.01455.x.
10. Ben-Haim, S. A., Osadchy, D., Schuster, I., Gepstein, L., Hayam, G., & Josephson, M. E. (1996). Nonfluoroscopic, in vivo navigation and mapping technology. Nature Medicine, 2, 1393–1395.
11. Gepstein, L., Hayam, G., & Ben-Haim, S. A. (1997). A novel method for nonfluoroscopic catheter-based electroanatomical mapping of the heart: in vitro and in vivo accuracy results. Circulation, 95, 1611–1622. doi:10.1161/01.CIR.95.6.1611.
12. Baan, J., van der Velde, E. T., de Bruin, H. G., Smeenk, G. J., Koops, J., van Dijk, A. D., Temmerman, D., Senden, J., & Buis, B. (1984). Continuous measurement of left ventricular volume in animals and humans by conductance catheter. Circulation, 70, 812–823. doi:10.1161/01.CIR.95.6.1611.
13. Steendijk, P., & Baan, J. (2000). Comparison of intravenous and pulmonary artery injections of hypertonic saline for the assessment of conductance catheter parallel conductance. Cardiovascular Research, 46, 82–89.
14. Steendijk, P., Baan, J., Jr., Van Der Velde, E. T., & Baan, J. (1998). Effects of critical coronary stenosis on global systolic left ventricular function quantified by pressure-volume relations during dobutamine stress in the canine heart. Journal of the American College of Cardiology, 32, 816–826. doi:10.1016/S0735-1097(98)00313-1.
15. Ten Brinke, E. A., Klautz, R. J., Verwey, H. F., van der Wall, E. E., Dion, R. A., & Steendijk, P. (2010). Single-beat estimation of the left ventricular end-systolic pressure-volume relationship in patients with heart failure. Acta Physiologica, 198, 37–46. doi:10.1111/j.1748-1716.2009.02040.
16. Sluijter, J. P. G., Smeets, M. B., Velema, E., Pasterkamp, G., & de Kleijn, D. P. V. (2004). Increased collagen turnover is only partly associated with collagen fiber deposition in the arterial response to injury. Cardiovascular Research, 61, 186–195.
17. Li, S. R., Qi, X. Y., Hu, F. L., et al. (2008). Mechanisms of improvement of left ventricle remodeling by trans-planting two kinds of autologous bone marrow stem cells in pigs. Chinese Medical Journal, 121, 2403–2409.
18. Schachinger, V., Erbs, S., Elsasser, A., et al. (2006). Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction. New England Journal of Medicine, 355, 1210–1221. doi:10.1056/ NEJMoa060186.
19. Huikuri, H. V., Kervinen, K., Niemela, M., et al. (2008). Effects of intracoronary injection of mononuclear bone marrow cells on left ventricular function, arrhythmia risk profile, and restenosis after thrombolytic therapy of acute myocardial infarction. European Heart Journal, 29, 2723–2732. doi:10.1093/eurheartj/ehn436.
20. Cao, F., Sun, D., Li, C., et al. (2009). Long-term myocardial functional improvement after autologous bone marrow mononuclear cells transplantation in patients with ST-segment elevation myocardial infarction: 4 years follow-up. European Heart Journal, 30, 1986–1994. doi:10.1093/ eurheartj /ehp220.
21. Perin, E. C., Willerson, J. T., Pepine, C. J., et al. (2012). Effect of transendocardial delivery of autologous bone marrow mononuclear cells on functional capacity, left ventricular function, and perfusion in chronic heart failure: the FOCUS-CCTRN trial. JAMA, 307, 1717–1726. doi:10.1001/ jama.2012.418.
22. Santoso, T., Siu, C. W., Irawan, C., et al. (2014). Endomyocardial implantation of autologous bone marrow mononuclear cells in advanced ischemic heart failure: a randomized placebo-controlled trial (END-HF). Journal of Cardiovascular Translational Research, 7, 545–552. doi:10.1007/s12265-014-9580- 6.
23. Williams, A. R., Trachtenberg, B., Velazquez, D. L., et al. (2011). Intramyocardial stem cell injection in patients with ischemic cardiomyopathy/novelty and significance. Circulation Research, 108, 792–796. doi:10.1161/CIRCRESAHA.111.242610.
24. Heldman, A. W., DiFede, D. L., Fishman, J. E., et al. (2014). Transendocardial mesenchymal stem cells and mononuclear bone marrow cells for ischemic cardiomyopathy: the TAC-HFT randomized trial. JAMA, 311, 62–73. doi:10.1001/jama.2013.282909.
25. Poh, K. K., Sperry, E., Young, R. G., Freyman, T., Barringhaus, K. G., & Thompson, C. A. (2007). Repeated direct endomyocardial transplantation of allogeneic mesenchymal stem cells: safety of a high dose, “off-the-shelf”, cellular cardiomyoplasty strategy. International Journal of Cardiology, 117, 360–364. doi:10.1016/j.ijcard.2006.04.092.
26. Diederichsen, A. C. P., Moller, J. E., Thayssen, P., Videbaek, L., Saekmose, S. G., Barington, T., & Kassem, M. (2010). Changes in left ventricular filling patterns after repeated injection of autologous bone marrow cells in heart failure patients. Scandinavian Cardiovascular Journal, 44, 139–145. doi:10.3109/ 14017430903556294.
27. Yao, K., Huang, R., Sun, A., et al. (2009). Repeated autologous bone marrow mononuclear cell therapy in patients with large myocardial infarction. European Journal of Heart Failure, 11, 691–698. doi:10.1093/eurjhf/hfp062.
28. Gavira, J. J., Nasarre, E., Abizanda, G., et al. (2010). Repeated implantation of skeletal myoblast in a swine model of chronic myocardial infarction. European Heart Journal, 31, 1013–1021. doi:10.1093/eurheartj/ehp342.
29. Siegel, G., Krause, P., Wöhrle, S., et al. (2012). Bone marrow-derived human mesenchymal stem cells express cardiomyogenic proteins but do not exhibit functional cardiomyogenic differentiation potential. Stem Cells and Development, 21, 2457–2470. doi:10.1089/scd.2011.0626.
30. Seeger, F. H., Rasper, T., Bönig, H., et al. (2014). The challenges of autologous cell therapy: systemic anti-thrombotic therapies interfering with serum coagulation may disable autologous serum-containing cell products for therapeutical use. Journal of Cardiovascular Translational Research, 7, 644–650. doi:10.1007/s12265-014-9584-2.